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The  zoonotic  roundworms  Toxocara  canis  and  T. cati  are  not  only  present  worldwide  in  their
deﬁnitive hosts;  they  also  frequently  occur  in  other  animal  species,  including  humans.  In
those so-called  paratenic  hosts,  the  larvae  do  not  develop  into  the  adult  stage,  but rather
migrate throughout  the  somatic  tissue  and  persist  as  infectious  L3  stage  for extensive
periods.  Those  arrested  larvae  may  lead to  severe  inﬂammatory  reactions  and  consequently
to a wide  range  of  pathological  and  clinical  manifestations.  However,  the  infected  paratenic
hosts also  constitute  a potential  source  of  infection  for the  deﬁnitive  hosts  or  humans
who  may  also  function  as paratenic  hosts.  In the present  review,  current  knowledge  of
larval migration  in a variety  of possible  paratenic  hosts  is summarized  including  variations
of migration  routes  and  susceptibilities.  Furthermore,  information  about  the  clinical  and
pathological  changes  for  the presented  species  and possible  consequences  of the  somatic
migration of larvae,  i.e. the  resulting  tissue  damage  as well  as adverse  host  reactions  to
arrested  larvae  are reviewed.  There  are  still  many  questions  unanswered  regarding  larval
behaviour in hosts  other  than  their  deﬁnitive  host.  Therefore,  it is  of  great  importance  to
continue further  elaboration  on the  biology  of  Toxocara  spp.  to prevent  further  spreading
of larvae  in both  the  paratenic  and  the deﬁnitive  host.. Introduction
Toxocara canis (Werner, 1782) and T. cati (Schrank 1788)
re  usually gastrointestinal helminths in canids and felids,
espectively. Up to 200,000 eggs may  be produced by the
emale  Toxocara spp. worm which are shed into the envi-
onment and raise the potential infection risk (Glickman
nd Schantz, 1981). Even though dogs and cats are the
eﬁnitive host, larvae may  also persist or even cause severe
isease  in a variety of paratenic host species. Hatching lar-
ae  behave similarly in the paratenic host compared to the
eﬁnitive  host, however, development into the adult stage
oes  not occur and infectious third-stage larvae (Brunaská
t  al., 1995) persist in tissues as a developmentally arrested
tage.  Their importance as zoonotic agents should not
e  underestimated since toxocarosis is one of the most
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reported zoonotic helminth infections worldwide and has
therefore  led to an increasing interest in the biology and
epidemiology of the genus Toxocara (Magnaval et al., 2001).
Prevalence of Toxocara spp. in either host depends
on the environmental as well as the hygienic conditions
in the surroundings. When shed into the environment
by the deﬁnitive host, eggs are not infective and take
about 3–6 weeks to embryonate and become infectious
(Overgaauw, 1997b). Infection risk increases with geopha-
gia  or soil eating as well as poor personal hygiene. Eating
raw  garden vegetables may  also lead to infection if contam-
ination through the deﬁnitive host has occurred (Magnaval
et  al., 2001). Human seroprevalence in European countries,
namely France, the Czech Republic and Austria, ranges from
2%  to 44% with higher values in rural areas (Magnaval et al.,
1994a;  Uhlíková and Hübner, 1998; Deutz et al., 2005).
Open access under CC BY license.In  tropical countries, seroprevalence ranges from 63% in
Bali,  Indonesia, (Chomel et al., 1993) to almost 93% in La
Réunion, France, (Magnaval et al., 1994b) highlighting the
need  for prevention of transmission. Parks and playgrounds
 Parasito
distributed into the liver that way. Most larvae remain
there, but some actively leave the liver. There have been
attempts to explain the greater neuroafﬁnity of T. canis-
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are a potential infection risk for transmission of eggs due
to  contamination by people routinely walking their pets
in  those areas. Additionally, stray cats and dogs may  also
contribute to contamination as well as fox populations in
urban  and rural areas (Castillo et al., 2000; Reperant et al.,
2007).  Toxocara canis eggs are mostly found in public parks,
whereas T. cati eggs are commonly found in sand boxes
(Jansen et al., 1993). To date, it is not clear whether T. cati
exhibits the same zoonotic risk as T. canis, since most infec-
tions  found in humans are considered to be caused by T.
canis.  However, antigenic fractions are shared and exper-
imentally infected animal models show that both species
behave in a similar way after hatching. Therefore, it can
be  assumed that the zoonotic risk and the behaviour in
paratenic hosts are comparable (Fisher, 2003; Cardillo et al.,
2009).  The risk of environmental contamination increases
with  infected deﬁnitive hosts shedding eggs into the envi-
ronment. Infection rates in Europe range from 3.5% to 34% T.
canis-infected dogs from different environments (e.g. pets,
dogs  from animal shelters or stray dogs) and from 8% to
76%  T. cati-infected cats (Parsons, 1987; Overgaauw, 1997c;
Fok  et al., 2001; Lee et al., 2010). Prevalences, especially in
stray  animals, highlight the need to understand the biology
of  this parasite in hosts other than the deﬁnitive one. Since
not  only humans may  take up eggs from the environment,
but a number of other animals as well, infection risk rises.
Even  though paratenic hosts do not shed eggs into the envi-
ronment, they may  be preyed upon by the deﬁnitive hosts
in  which the arrested larvae are reactivated and continue
development into egg laying adults.
In this review, current literature regarding different
paratenic hosts, larval distribution and the pathological
changes as well as the impact on the host by T. canis in
contrast to T. cati will be discussed in detail.
2. Larval migration
2.1.  Larval migration in the deﬁnitive host
In general, T. canis or T. cati larvae hatch 2–4 h after
ingestion of embryonated eggs in the duodenum, where
they  penetrate the intestinal walls to enter the circula-
tory system. The liver is reached about 24 h post infection
via portal circulation through venous capillaries (Webster,
1958b). About 12 h later, larvae continue migration to the
heart  where the lung is reached via the pulmonary artery.
From there on the migration route strongly depends on sev-
eral  factors such as the age and the immune status of the
host  as well as the infectious dose ingested. Larvae may
penetrate the alveoli wall leading to migration to the phar-
ynx  through bronchioles and trachea. After subsequent
swallowing, larvae start developing into adult worms in the
intestine,  which they reach about 7–15 days after tracheal
migration (Sprent, 1958). Another possibility of migration
from the lung is entering the circulatory system again after
penetration of the alveoli walls, in which case larvae are
passively distributed to the somatic tissue (Sprent, 1956;
Webster, 1958a,b).
Larvae,  which have been taken up with an infected
paratenic host, are also able to develop directly, probably
due  to a higher degree of maturity (Overgaauw, 1997b).logy 193 (2013) 375– 389
They  may  therefore exhibit aberrations in their migration
patterns, i.e. a lack of tracheal migration. Nevertheless,
normal migration routes have been described after con-
sumption of an infected paratenic host (Warren, 1969).
2.2.  Larval migration in the paratenic host
In general, the migration pattern in the paratenic host
is  comparable to the one in the deﬁnitive host. However,
larval distribution largely depends on the infected species.
Commonly, larvae hatch after consumption, penetrate the
intestinal  wall and during the so-called hepato-pulmonary
phase migrate via circulatory system to the liver and then
to  the lungs. From there, they continue migration into
the  systemic circulation. During the visceral phase they
are  distributed throughout the entire body according to
species-dependent predilection sites (Abo-Shehada and
Herbert,  1984a; Magnaval et al., 2001). Afterwards they
persist  in the tissue as the infectious stage for extended
periods of time (Sprent, 1952). As encapsulated larvae, they
remain  viable for up to 10 years (Fig. 1). This way they may
continue their life cycle at prolonged periods after infec-
tion  if the paratenic host is consumed by the deﬁnitive host
(Beaver,  1969; Maruyama et al., 1994; Oryan et al., 2010;
Taira  et al., 2011).
Migration  routes as well as predilection sites depend on
the  host species, however nearly all organs may  be affected
with  varying degrees of larval burdens. In the paratenic
host, T. canis seems to exhibit an afﬁnity to the CNS whereas
the  brain and the eyes are commonly infected at later time
point  post infection. Toxocara cati shows similar migration
behaviour towards the CNS but seems to migrate more
slowly (Burren, 1972; Glickman and Summers, 1983; Alba-
Hurtado  et al., 2000; Akao et al., 2003a).
It has been suggested that the degree of blood supply
of the different organs plays a role in larval distribution,
since larvae are entering the circulatory system and areFig. 1. Toxocara cati larva recovered from the muscle of a mouse after
artiﬁcial digestion (Institute for Parasitology, archive).
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ati larvae are smaller, they may  therefore be able to leave
rteries more easily, while T. canis larvae are less likely to
eave  the circulatory system and ﬁnally remain arrested
n  the brain (Bisseru, 1969; Dunsmore et al., 1983). Pos-
ibly,  clinical consequences of this neuroafﬁnity, such as
ehaviour  alterations resulting in an increased probability
f  being consumed by canid or felid species, may  serve as an
volutionary explanation for the parasite’s migration route
Olson  and Rose, 1966; Cox and Holland, 1998; Hamilton
t  al., 2006; Chiefﬁ et al., 2010).
. Paratenic hosts
The  inﬂuence of migrating Toxocara spp. larvae, mainly
.  canis, in paratenic hosts has been intensively studied
n  a variety of animal models. These models mainly serve
s  a potential comparison to human toxocarosis and give
aluable  hints to host-parasite interactions. However, the
ossibility of severe differences between the animal model
nd  human infection biology should not be underesti-
ated (Boes and Helwigh, 2000). Some animal models are
ore  suitable than others, depending on their suscepti-
ility. Organ affection by migrating larvae, effects at time
oints  post infection, as well as the relative distribution and
urvival,  are host species dependent. The most important
nimal models are described in detail below.
.1. Rodents
Several rodents are used as animal models for toxo-
arosis, the mouse being the most common. However, rats
nd  gerbils have also been shown to be very useful in the
tudy  of larval migration, behavioural changes, as well as
he  pathology of migrating larvae.
.1.1. Mouse strains
Different  mouse strains exhibit a wide range of sus-
eptibility with some strains being resistant and some
etaining high larval counts in somatic tissues. Several
tudies have been conducted to investigate larval distri-
ution and strain dependent differences. There are several
ifferences between inbred and outbred mouse strains.
urthermore, larval counts are highly dependent on inoc-
lation  dose and the day post infection (Kayes et al., 1985;
avasiová-Reiterová et al., 1995; Cox and Holland, 1998;
llero  et al., 2008).
In  general, the migratory behaviour consists of two
hases, namely the hepato-pulmonary phase and the
yotropic-neurotropic phase. The ﬁrst one occurs during
he  ﬁrst week post infection when larvae reach liver and
ungs,  the latter when larvae migrate through the body and
ccumulate in the carcass and the brain (Abo-Shehada and
erbert,  1984a). After distribution of the larvae, they arrest
n  the tissue and persist as the infectious stage for at least
ne  year (Sprent, 1952; Burren, 1968).
Havasiová-Reiterová et al. (1995) directly compared
oth roundworm species in C57Bl6/J mice and observed
hat low infection doses (5–500 eggs) resulted in similar
istribution of both Toxocara species. None of the T. canis-
nfected mice with those low doses presented larvae in the
iver.  With the high infection dose (1000 eggs), only onelogy 193 (2013) 375– 389 377
larva  could be found in the liver and most were found in
the  brain and in the muscle at day 70 p.i. T. cati, in com-
parison, was  mostly found in the muscle and did not seem
to  accumulate in the brain, indicating a different migra-
tion  route (Havasiová-Reiterová et al., 1995). The same
phenomenon could be observed by other authors (Bisseru,
1969;  Piergili Fioretti et al., 1989; Camparoto et al., 2008).
Direct  comparison of both species showed that T. cati did
not  penetrate the brain, leading to the conclusion that T.
canis  is the causal agent of human neurotoxocarosis. How-
ever,  larval numbers of T. canis also decreased over time
post  infection (Burren, 1971). In “white mice”, larval distri-
bution  was  determined for T. canis and T. cati leading to the
conclusion that the hatching of T. cati seems more rapid
than  the hatching of T. canis. This is based on the obser-
vation that 48 h after infection with T. canis, most larvae
were found in the liver, after 4 days in the lung and heart
and  after 14 days in the brain. Larvae were found in muscle
from  day 4 on. For T. cati, larvae reached the liver after day
1,  the lung on day 2, and the leg muscle on day 3. Larvae
could be detected in the brain on days 2–28 p.i. (Prokopic
and Figallová, 1982).
Migration  routes in Clarke’s OS1 mice were investigated
using an infectious dose of 1000 eggs of either T. canis or T.
cati  showing that brains and eyes of some T. canis-infected
mice contained larvae. Larvae could be found in each part
of  the brain, however, most were found in the cerebellum.
Before day 7 of infection, the number increased with time
and  stayed constant between day 7 and 44 p.i. Between
days 119–138 p.i., the number of larvae decreased. Some
larvae could be found in spinal cords of a couple of individ-
uals.  For T. cati, no larvae could be observed in the eye and
only  single larvae could be detected in the brain (Burren,
1971). The low detection rate of T. cati larvae found in CNS
tissue  of mice supports an earlier study by Dubey (1968)
who  found the larvae to be present in the brain for at least
8  weeks, however in very small numbers.
BALB/c mice seem exceptionally susceptible to T. canis
infection as larval counts are much higher compared to
other  strains with a maximum number of larvae in the
brain  on day 8–21 p.i. (Bardón et al., 1994; Epe et al., 1994).
Epe  et al. (1994) determined differences in several mouse
strains (BALB, C3H, C57Bl, DBA and NMRI) and found that
even  though the larval numbers were highest in BALB/c
mice, they usually did not show any clinical symptoms,
whereas many individuals of the other strains deceased
between weeks 17–21 p.i. after showing central nervous
symptoms. The highest larval burden resulted in the lowest
morbidity and mortality. Due to their distinct susceptibil-
ity, BALB/c mice were found the most suitable model for
toxocarosis in several studies (Pinelli et al., 2001; Hamilton
et  al., 2006; Ollero et al., 2008). This susceptibility could also
been  shown for T. cati infection in BALB/c mice in which
migration until day 28 p.i. was reported. Observed degen-
erative muscle ﬁbres in the heart might indicate active
migration through the myocardium (Cardillo et al., 2009).
Regardless of the mouse strain, the migration route of T.
canis  and T. cati was  comparable in all experiments, as for
both  larval counts were highest in liver and lungs (Fig. 2)
at  the beginning of the experiment, with later accumu-
lation in the brain (Fig. 3) (Skerrett and Holland, 1997).
378 C. Strube et al. / Veterinary Parasitology 193 (2013) 375– 389Fig. 2. Toxocara spp. larva in the lung of an infected mouse (Institute for
Parasitology, archive).
Additionally, accumulation of T. cati in the muscle tis-
sues  was observed (Cardillo et al., 2009). Outbred strains
seem to be less susceptible than inbred mouse strains, even
though  migration patterns were comparable (Canberra vs.
C57Bl/6J).  It was hypothesized that the outbred strain can
trap  larvae in the liver and thereby prevent systemic circu-
lation  thereby (Dunsmore et al., 1983). Larval persistence
in Balb/c mice was determined for up to one year whereas
brain and musculature were mainly colonized. After one
year  larval numbers were found to be diminishing (Bardón
et  al., 1994). Additionally, invasion of the spinal cord in
mice  infected with T. canis was observed and data showed
that  larvae invade the spinal cord early and persist there
for  at least 4 months, possibly causing the observed motor
problems (Olson and Petteway, 1972).
Behavioural studies following T. canis infections were
mainly conducted in LACA mice which were infected with
doses  ranging from 100–3000 eggs. It could be shown that
there  are strong correlations between numbers of larvae
recovered from brains of T. canis-infected mice and social
behaviour as well as anxiety. High numbers lead to abnor-
mal  social behaviour in terms of reduced aggressiveness
whilst low larval numbers lead to a decreased amount of
risk  assessment. Both factors result in greater suscepti-
bility to potential predators in the environment (Cox and
Holland,  1998, 2001; Hamilton et al., 2006). Additionally,
Fig. 3. Toxocara canis larva in the brain of an infected mouse (Institute for
Parasitology, archive).Fig. 4. Toxocara canis larva in the cerebellum (Institute for Parasitology,
archive).
a more detailed study revealed that high larval burdens
in  the brain start accumulating day 26–45 p.i. and mice
show behavioural alterations accordingly (Burren, 1971;
Skerrett and Holland, 1997). Immobility was  increased and
a  decrease of exploratory behaviour was  shown. Mice were
less  active, less aggressive, spent more time in open areas
and  showed impairment of learning and memory (Holland
and  Cox, 2001).
3.1.2.  Rats
Rats  are considered a potential paratenic host as well,
but  are considerably neglected as opposed to mice concern-
ing  research. Comparison of larval distribution of T. canis
and  T. cati in rats revealed a similar migration pattern of
larvae  as seen in mice. Larval recovery of T. canis in liver,
lungs, carcass, and brain indicates a hepato-pulmonary
phase during the ﬁrst week of infection as high numbers
of  larvae were counted in the liver between day 3 and 5 p.i.
of  experimentally infected rats. High larval counts could be
observed  in the lungs between day 5 and 8 p.i., and in the
carcass  and in the brain from day 5 p.i. on (Lescano et al.,
2004).  Analysis of larval migration with focus on the CNS
revealed that larvae started invading the brain from day 6
p.i.  on and could be found until day 28 p.i., the last study
day. Notably, as in mice most larvae were detected in the
cerebellum (Fig. 4). Only very few individual rats retained
larvae in their spinal cords and none retained larvae in their
eyes  (Burren, 1971, 1972).
The T. canis larval counts in the brain are connected to
a  prolonged learning behaviour as massive impairment of
the  ability to solve complex maze problems was  exhib-
ited by the infected groups (Olson and Rose, 1966). The
start  of larval invasion of the brain could be observed
between day 3 and 7. In addition, behavioural changes
after T. canis infection have been observed in terms of
mobility. Infected rats lose their natural caution in an
open  ﬁeld apparatus by exhibiting higher levels of mobility
and  exploratory behaviour. Furthermore, muscle strength
impairment was measured 30 days p.i. These factors con-
tribute  to the assumption that rats as paratenic hosts are
inﬂuenced by somatic larvae turning them into easier prey
for  the deﬁnitive host in nature (Chiefﬁ et al., 2009, 2010).
In  contrast, larval distribution of T. cati in rats revealed that
larval  migration to the brain was  a lot less frequent and
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ainly observed on day 15 and 30 p.i. Overall, larval dis-
ribution was comparable to T. canis larvae for liver and
ungs  but larval numbers were lower. The bulk of larvae
ere found in the carcass, almost rounding up to 100%
n  relation to the infection dose. Eyes had been examined
nd larvae could be found on some occasions (Santos et al.,
009).  From the migration pattern described above, Santos
t  al. (2009) concluded that there are signiﬁcant differences
etween T. cati and T. canis migration routes and their neu-
al  afﬁnity. Santos et al. (2009) investigated distribution
f larvae until day 60 p.i. and showed that T. cati larvae
igrate to the brain at a slower rate than T. canis. In addi-
ion,  Zibaei et al. (2010) demonstrated that the T. cati larval
urden  in the brain did not increase until day 70–95 p.i.
.1.3.  Gerbils
Gerbils are frequently proposed as a suitable model for
uman  ocular toxocarosis due to their high susceptibility
o the ocular form of the parasitosis as well as in terms of
nduced  inﬂammatory responses, immune responses and
ost  protective mechanisms (Alba-Hurtado et al., 2009).
oxocara canis migration dynamics determined by Alba-
urtado et al. (2009) revealed that from 12 to 24 h p.i.,
arvae could be found in the lung and liver but the majority
as  still located in the intestine. Between day 3 and 5 p.i.,
arvae  were mainly recovered from the lungs, and from day
0  to 60 p.i. from the carcass. Larvae were present in the
yes  from day 5 p.i. until the end of the experiment (day
0  p.i.) and most larvae were recovered from the brain on
ay  20–60 p.i. Relative distribution was calculated based on
he  organ’s weight and in conclusion neuroafﬁnity turned
ut  to be much higher than afﬁnity to the muscle. Over-
ll,  the migration route could be divided into two  phases,
amely the visceral phase and the myotropic-neurotropic
hase. In contrast to different paratenic hosts like mice,
ost  larvae were recovered from the lung instead of the
iver.  The second phase lasted up to days 10–60 p.i. (Alba-
urtado et al., 2009). The same afﬁnity to the CNS was
ound by Burren (1972) who investigated brains of gerbils
nd  recovered high larval numbers in the cerebellum. Few
arvae  continued to migrate into the spinal cord.
Comparison of T. cati and T. canis in gerbils revealed a
imilar severe effect of the somatically migrating larvae.
ver  half of the gerbils in both groups showed neurologi-
al abnormalities which progressed in gerbils infected with
.  canis 50 days p.i., whereas gerbils infected with T. cati
id  not show abnormalities until 120 days p.i. Most larvae
ere  repeatedly found in the cerebellum and pathological
hanges were identical for both Toxocara species with lar-
ae  and lesions apparently existing separately (Akao et al.,
003b).  On day 7 p.i., considerably more T. canis larvae
han T. cati larvae were detected in the brain (Akao et al.,
000).  These ﬁndings are supported by other authors who
ound  that just one day after initial infection, 50% of T. canis
nfected  gerbils contained larvae in their eyes whereas ocu-
ar  T. cati larvae were detected at day 5 p.i. Additionally, it
as  shown that after T. cati infection, larvae could be recov-
red  from the muscle on day 70 p.i. whereas on day 92
.i.  they were recovered in large numbers from the brain
Zibaei et al., 2010). It was observed that gerbils infectedlogy 193 (2013) 375– 389 379
with  either T. cati or T. canis, exhibited lack of coordination
and immobility (Alba-Hurtado et al., 2000, 2009).
The optic nerve is thought to be an important part of the
migration route for larvae in OLM in gerbils infected with T.
canis.  Investigations on gerbil eyes on several days between
0.5  and 60 days p.i. revealed that 90% of the eyes contained
larvae (Alba-Hurtado et al., 2000). Larvae are thought to
remain  in the brain until the host’s physiological status
changes and then the larvae migrate to the eye where they
can  elicit severe ophthalmic changes (Takayanagi et al.,
1999;  Akao et al., 2000; Alba-Hurtado et al., 2000).
3.2. Other mammals
3.2.1.  Pigs
Experimental infections of pigs with T. canis have been
conducted quite frequently in order to propose a model for
human  toxocarosis since the pig’s immunological response
is  comparable to the human’s as well as its many phys-
iological and biochemical similarities (Miller and Ullrey,
1987;  Helwigh et al., 1999). No experimental infections of
pigs  with T. cati could be found in the literature; therefore
the migratory route of this species in this particular host
remains to be determined.
As  in the above described paratenic hosts, larvae accu-
mulated in the liver. However, larval recovery was also
possible in lungs, heart, brain, and muscles on days 10–21
p.i.  Lymph nodes of the small intestine seemed to be the
starting  point of larval migration to the liver indicated by
high  larval counts in lymph nodes around small and large
intestines at the beginning of infections. No larvae were
detected in the eye on any occasion (Burren, 1968; Helwigh
et  al., 1999; Sommerfelt et al., 2004). Viable persistence in
the  pigs’ tissue was demonstrated by successfully infecting
mice  with somatic larvae recovered from pigs (Sasmal et al.,
2008).  However, larvae do not seem to persist in the pigs’
tissues  for prolonged periods of time since a signiﬁcant
decrease in larval numbers had been observed during time
points  7, 14, and 21 days p.i. (Helwigh et al., 1999). After
126  days p.i., no larvae were recovered at all, indicating
self-limiting factors (Sommerfelt et al., 2004).
3.3. Avian species
Beside  mammals, birds were subjected to experimen-
tal infections to extend knowledge of somatic migration of
Toxocara  spp. larvae in paratenic hosts. Overall, the adapt-
ability  of Toxocara spp. larvae to the mammalian host seems
to  be greater than to the avian host (Pahari and Sasmal,
1990).
3.3.1. Poultry
Comparable to pigs, paratenic chicken hosts serve as
a  potential source of infection for humans and other
mammals. Therefore, chickens have been experimentally
infected with either Toxocara species to determine lar-
val  distribution, larval persistence and viability in order
to  assess the infection risk for humans, as accumulating
evidence links toxocarosis in humans to the consump-
tion of undercooked chicken (Ito et al., 1986; Nagakura
et al., 1989). Since larvae in chicken meat have been shown
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to be extremely infective even after an extended period
of  time or prolonged periods of low temperatures, Tox-
ocara  spp. infected chickens pose a potential health risk
(Sprent, 1953; Taira et al., 2011, 2012). Chickens kept in
free-ranging systems are likely to ingest embryonated eggs
or  infected paratenic hosts like earthworms (Pahari and
Sasmal,  1991).
Investigations of the possible hepato-pulmonary migra-
tion  of T. canis in chickens revealed the highest larval
burdens in the liver and the lungs, while only few larvae
were recovered from other tissues. It is assumed that T.
canis  larvae leave the intestine after hatching around 24 h
p.i.  and start migration to the liver, which they in turn leave
and  migrate to the lungs around day 3 p.i. Re-migration to
the  liver occurs around day 6 p.i., most likely via the cir-
culatory system. A small number of larvae was recovered
from the breast muscle, the brain, the heart and duode-
num 3 days p.i., possibly indicating alternative routes of
migration  (Taira et al., 2003a). The liver as predilection site
may  harbour persisting T. canis larvae for 3 month to 3.5
years  (Beaver, 1956; Galvin, 1964; Tsvetaeva et al., 1979;
Maruyama et al., 1994).
Contrarily, assessment of the migration route of T. cati
revealed highest larval counts in the liver and the brain 14
days  p.i., however, the total number of recovered larvae was
rather  low (Azizi et al., 2007). In a follow-up study, chronic
infections were observed until day 240 p.i. However, larvae
were  detected solely in the brain and only in low numbers
(Oryan et al., 2010).
3.3.2.  Other avian species
In  pigeons experimentally infected with T. canis, a total
recovery rate of 4–27% was achieved with the majority
of larvae persisting in the liver and lungs as demon-
strated in chickens previously. Some degree of tracheal
migration is suspected in pigeons, because large numbers
of  larvae could be observed in the lungs at the begin-
ning of infection and relatively few in somatic tissue later
on  (Galvin, 1964). Furthermore, a remarkable amount of
larvae  persists in the liver for up to 3 months (Beaver,
1956).
Japanese quails showed similar distribution patterns
to chickens with the highest number of recovered lar-
vae  in the liver at day 10, 20 and 30 p.i., whereas
only few larvae were found in muscle, brain and heart
tissue. Larvae recovered from these animals revealed
infectious potential as they reappeared in mice tis-
sues after experimental infection (Pahari and Sasmal,
1990).
3.4. Humans and primates
Many  cases of toxocarosis in humans have been
observed caused by ingested embyronated eggs from soil
or  infective larvae from undercooked meat (Glickman and
Schantz,  1981; Ito et al., 1986; Stürchler et al., 1990;
Aragane et al., 1999; Magnaval et al., 2001). Larval distribu-
tion  has only been observed for T. canis in very few studies
including primates: Crab-eating macaques (Macaca fascic-
ularis)  infected with embryonated eggs of T. canis suffered
from acute and chronic phases of the infection. However,logy 193 (2013) 375– 389
as  tissues were not investigated for presence of larvae,
the  migration route remains unclear, but CNS lesions indi-
cate  larval migration to the brain, supporting the assumed
neuroafﬁnity of T. canis (Glickman and Summers, 1983).
Neuroafﬁnity in primates was  also shown by Tomimura
et al. (1976), who observed larvae in the cerebrum of
infected Macaca spp. besides liver and lung tissue. Occa-
sionally larvae were detected in the spinal cord. Severe
neurological signs could be observed on day 8–16 p.i., lead-
ing  to the assumption that larvae start migrating to the
brain  around that time. Persistence and survival of larvae
was  noted up to 15 months in the eyes of monkeys and up to
10  years in other tissues (Beaver, 1969). It was  suggested
that larvae retain the ability to actively migrate through
ocular tissue and exit via the optical nerve (Watzke et al.,
1984).  However, deﬁnite migration routes have yet to be
determined.
4.  Continuance of somatic larvae
Somatic larvae can complete their lifecycle after inges-
tion of the paratenic host by the deﬁnitive host (cf.
Section 2.1). Another possibility of larvae continuance
is transmission to the offspring, which, at least in
the deﬁnitive host, provides again the opportunity to
reach  adulthood and thus the completion of the life
cycle.
4.1.  Transmission to the offspring in the deﬁnitive host
Transmission of somatic larvae to the deﬁnitive hosts’
offspring plays an important role in the lifecycle of Toxo-
cara  species. This form of transmission usually occurs at
a  very early point of development resulting in a very high
prevalence among puppies and kittens. With increasing age
of  the host, the development of infective larvae to adult
worms  decreases, which is thought to be connected to
acquired immunity (Greve, 1971; Oshima, 1976; Barriga,
1988).
Canids, as the deﬁnitive host for Toxocara canis, have
a  high chance of getting infected as soon as they reach
the foetal stage (Koutz et al., 1966). Infection of the foetus
may  either be induced by oral ingestion of embryonated
eggs by the bitch during pregnancy, or reactivation of
somatic tissue larvae which are suggested to reach the foe-
tuses  by transplacental transmission (Shillinger and Cram,
1923;  Yutuc, 1949; Webster, 1958a; Scothorn et al., 1965;
Schnieder et al., 2011). Transplacental transmission is the
common  route of infection whereas lactogenic transmis-
sion is of minor importance in dogs (Burke and Roberson,
1985a,b).
In  contrast, the primary transmission route of T. cati
in  cats is deﬁned as lactogenic (Sprent, 1956; Swerczek
et al., 1971; Coati et al., 2004). If infection occurs during
the  pregnancy of the queen, it is assumed that the larvae
migrate directly to the mammary glands, ensuring survival
and  further development of the larvae by vertical transmis-
sion  (Swerczek et al., 1971). Reactivation of T. cati larvae
arrested in the somatic tissue of the cat and migration to
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splenomegaly, as well as lower respiratory symptoms such
as  coughing, bronchospasms and asthma caused by par-
asitic  pneumonia or bronchitis (Kayes and Oaks, 1978;
Magnaval et al., 2001; Despommier, 2003). LaboratoryC. Strube et al. / Veterinary
he mammary glands seem to be less frequent (Coati et al.,
004).
.2.  Transmission to the offspring in the paratenic host
To  date, no ﬁnal conclusions can be drawn on whether
r not prenatal or lactogenic infections play a major role
n  paratenic hosts. There are several studies dealing with
his  mode of transmission in the paratenic host concern-
ng  T. canis infection, however very few dealing with T.
ati.  For T. canis, prenatal transmission only seems to occur
nder  special conditions and only to a small extent. A
ossible explanation may  be the recurrent somatic migra-
ion  in the paratenic host as opposed to the very frequent
aematogenic migration in the deﬁnitive host. Therefore,
he  placenta may  not be affected. Indeed, several authors
ould not show any transplacental transmission in mice
Oshima, 1961; Taylor et al., 1996; Jin et al., 2008). How-
ver,  transplacental migration of T. canis larvae in mice was
emonstrated when mice were infected during pregnancy.
irst  signs of larval migration to the uterus and the pla-
enta were detected from day 9 of pregnancy while foetal
nfection started on day 11 of pregnancy (Lee et al., 1976).
urther evidence for transplacental transmission was pro-
ided  in very few cases (Oteifa et al., 1996; Reiterová et al.,
003).
By  contrast to the deﬁnitive host, lactogenic T. canis
ransmission seems to occur quite frequently in paratenic
osts. In this context it was shown for mice that larval
ounts in offspring as well as milk were high when mothers
ere  infected during pregnancy (Baumm and Stoye, 1981).
shima  (1961) demonstrated strong effects of gestation
nd lactation on T. canis distribution in mice. The author
uggests that the hormonal status during pregnancy plays
n  important role in reactivation of larvae. After injection
f  prolactin, a decrease in the number of T. canis larvae in
he  mice tissue was observed, leading to the conclusion
hat the hormone may  stimulate arrested larvae to con-
inue  migration. This study was supported by results by
in  et al. (2008), who also investigated the trans-lactational
aternal-neonatal transmission of T. canis larvae in mice
aking  the effect of prolactin into account.
Vertical transmission of T. cati in the paratenic host
as described in studies which provided similar data to
ertical  transmission of T. canis. Intrauterine transmis-
ion was observed on occasion in mice if they had been
nfected during gravidity (Prokopic and Figallová, 1982;
chön  and Stoye, 1986). Schön and Stoye (1986) demon-
trated that lactogenic transmission occurred frequently
hen the mother was infected around the time of con-
nement. The lactogenic infection rate of the offspring
ecreased as the time span between infection and lactation
ncreased. Furthermore, lactogenically infected offspring
evealed the ability to pass on larvae to their progeny
y lactogenic transmission as well. Notably, lactogenically
nfected offspring show partial protection against reinfec-
ion,  marked by a signiﬁcantly reduced amount of larvae
ompared to an orally infected control group (Reiterová
t al., 2006).
In  addition to larval transfer to the offspring, abor-
ion of foetuses is another important consequence oflogy 193 (2013) 375– 389 381
intrauterine transmission. A signiﬁcant decrease in mouse
litter  size compared to the control group as well as up to
54%  abortions could be observed if mothers were infected
at  an early gestational stage. Mothers’ larval numbers
decreased continuously while larva in the offspring could
ﬁrst  be detected from day 5 after birth onwards with grad-
ually  increasing numbers during the rest of the study. The
litter  size of mothers infected at late gestational stage
showed signiﬁcant differences from that of uninfected
mice, but only 21% suffered abortion (Reiterová et al., 2003).
These  ﬁndings concerning the inﬂuence of the infection
on litter size support an earlier study demonstrating a
decrease in litter size after infection (Akao et al., 1990).
5.  Clinical and pathological changes
5.1. Human toxocarosis
The  clinical picture of toxocarosis in humans has been
systematically classiﬁed in four groups: Visceral larva
migrans syndrome (VLM), neurological toxocarosis (NT),
ocular  larva migrans syndrome (OLM; Fig. 5) and the more
recently described covert toxocarosis (Magnaval et al.,
2001).  The broad spectrum of clinical and pathological
consequences of toxocarosis as well as the frequency of
unapparent infections may  cause some difﬁculty in identi-
fying  and classifying clinical cases. The severity and range
of  symptoms depends on the tissue invaded, the number
of  migrating larvae, and the age of the host. The immediate
hypersensitivity response to the death of larvae is thought
to  be the main cause for symptoms of VLM (Despommier,
2003). The ﬁrst VLM report described a multi-systemic dis-
ease  with hypereosinophilia and hepatomegaly in three
children (Beaver et al., 1952). Generally young children
(<5 years) are most often affected and usually present
with fever, abdominal pain, probably due to hepato- andFig. 5. Ocular larva migrans (Institute for Parasitology, archive).
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diagnosis in these patients commonly reveals leucocytosis,
persistent eosinophilia as well as hypergammaglobuli-
naemia and an elevated GT-level (Cypess, 1978; Schantz,
1989). Other organ involvement such as myocarditis, myal-
gia  with eosinophilic polymyositis, arthritis, and nephritis
may  also occur (Kayes and Oaks, 1978; Dromer et al., 1993;
Shetty  and Aviles, 1999; Prunier et al., 2001). VLM has
additionally been associated with dermatological changes
such  as rash, pruritus, excema, panniculitis, urticara and
vasculitis (Holland and Smith, 2006). Although generally
most T. canis infections remain unapparent, long-term
effects such as development of asthma and promotion
of pulmonary ﬁbrosis are suspected to occur (Aderele
and Oduwole, 1982; Grove, 1982; Richards et al., 1983;
de  Sylva et al., 1990; Feldman and Parker, 1992; Kayes,
1997).
The number of reported cases of neurotoxocarosis is
scarce  and varies between 29 (Moreira-Silva et al., 2004)
and  50 cases (Finsterer and Auer, 2007) listed in litera-
ture reviews of case reports from the early 1950s until
to  date. In contrast, various animal experiments have
indicated frequent CNS involvement in paratenic hosts
as  described below. Migration of Toxocara spp. larvae to
the  human brain is most often not associated with clini-
cal  central nervous signs, but may  in rare cases result in
eosinophilic meningitis, encephalitis, myelitis or combined
pathological presentations (Engel et al., 1971; Mikhael
et  al., 1974; Wang et al., 1983; Gould et al., 1985; Villano
et  al., 1992; Ota et al., 1994; Sommer et al., 1994; Barra
et  al., 1996; Duprez et al., 1996; Goffette et al., 2000; Vidal
et  al., 2003; Moreira-Silva et al., 2004; Mrissa et al., 2005;
Caldera et al., 2012). Cerebral vasculitis, which might even
develop  under anthelmintic therapy (Dousset et al., 2003;
Oujamaa et al., 2003; Xinou et al., 2003), optic neuritis
(Komiyama et al., 1995) and other cranial nerve involve-
ment (Moreira-Silva et al., 2004) as well as a case of
meningo-radiculitis (Robinson et al., 2002) have also been
described. Cerebral lesions are predominantly located in
the  white matter and additional occlusion of cerebral arte-
rial  vessels has been reported (Sommer et al., 1994; Xinou
et  al., 2003). Clinical patients present with a large vari-
ety  of symptoms according to their individual pathology
ranging from headache, fever, photophobia, weakness, dor-
salgia,  confusion, tiredness, visual impairment to epileptic
seizures, neuropsychological disturbances, dementia and
depression  (Marmor et al., 1987; Fortenberry et al., 1991;
Sommer et al., 1994; Richartz and Buchkremer, 2002;
Bachli et al., 2004; Finsterer and Auer, 2007). Furthermore,
motor impairment such as ataxia, rigor, para- or tetra-
paresis and dysaesthesia as well as urinary retention and
faecal  incontinence occurred in human cases of toxocaro-
sis  (Wang et al., 1983; Russegger and Schmutzhard, 1989;
Fortenberry et al., 1991; Villano et al., 1992; Sommer et al.,
1994;  Goffette et al., 2000; Moreira-Silva et al., 2004).
Ocular larva migrans syndrome (OLM) is characterized
by an eosinophilic immune response to larval migra-
tion into the eye. After formation of an eosinophilic
abscess, a granulomatous inﬂammatory reaction surrounds
the  larvae (Shields, 1984; Taylor, 2006). Histopathologi-
cal examinations revealed multiple retinal and vitreous
haemorrhages, eosinophilic abscesses and granulomatouslogy 193 (2013) 375– 389
lesions with or without larvae. The lack of larvae in some
lesions was attributed to destruction of the causative
organism and its mobility (Wilder, 1950; Lyness et al.,
1987;  Taylor, 2006). OLM occurs predominantly unilat-
erally. Bilateral ocular involvement has been described
but can be considered uncommon (Taylor, 2006). Clini-
cal  ﬁndings predominantly comprise visual impairment,
strabismus, leukocoria, solid retinal mass predominantly
at the posterior pole, vitreous mass or haze, vitritis, reti-
nal  detachment, cataract, endophthalmitis, papillitis and
uveitis.  Possible clinical consequences of OLM are blind-
ness  and secondary glaucoma (Brown, 1970; Gillespie
et  al., 1993; Despommier, 2003). The term “covert tox-
ocarosis” was  ﬁrst introduced by Taylor et al. (1987)
describing a non-speciﬁc clinical syndrome in children
caused by Toxocara spp. infection which could not be
subsumed under VLM, OLM or NT. Unspeciﬁc symptoms
such as fever, anorexia, nausea, headache, abdominal
pain, vomiting, sleep and behaviour disorders, pharyngitis,
pneumonia, cough, wheeze, limb pains, cervical lym-
phadenitis could be observed (Taylor et al., 1987; Magnaval
et  al., 2001).
5.2.  Toxocarosis in animal models
The haematological and serological changes in exper-
imental T. canis infection in primates such as macaques
(M.  fascicularis) are similar to the ones observed in chil-
dren  suffering from VLM (Glickman and Summers, 1983).
Furthermore, histopathological ﬁndings like granuloma-
tous hepatitis and encephalomyelitis are also consistent
with the disease induced by Toxocara spp. in humans and
the  other paratenic hosts described below. Throughout the
experiments carried out by Glickman and Summers (1983)
and  Tomimura et al. (1976), some of the monkeys devel-
oped neurological symptoms such as ataxia, nystagmus,
or paralysis. Additionally swelling of the tracheobronchial
lymph nodes, granulomatous lesions in lungs and kidneys
as  described in other paratenic hosts were reported. But
unlike  in humans, OLM does not occur in primates after
oral  infection. A clinical picture similar to human OLM has
only  been reported after artiﬁcial intravitreal injection of
larvae  (Watzke et al., 1984).
Mice  have frequently been used in studies investigating
the biology of Toxocara spp. infection. It has been noted that
different  in- and outbred strains of mice show varying lar-
val  distribution patterns and brain inﬂammatory immune
response (Koizumi and Hayakawa, 1984; Epe et al., 1994;
Cox  and Holland, 1998; Pinelli et al., 2008; Cardillo et al.,
2009).  Clinically, Toxocara canis-infected mice of various
strains present with behaviour alterations as described in
Section  3.1.1 and, furthermore, develop central nervous
symptoms such as dullness, somnolence, kyphosis, pare-
sis,  incoordination and tremor (Epe et al., 1994; Cox and
Holland, 2001). Epe et al. (1994) showed that a high lar-
val  CNS burden does not correlate with the severity of
the  symptoms, indicating that not mechanical damage by
migrating  larvae but underlying adverse immune reactions
are  causing the pathology. Pathohistological examinations
of infected mouse brains revealed demyelization, focal
malacia and mixed cell inﬁltration (Epe et al., 1994; Kayes,
C. Strube et al. / Veterinary Parasitology 193 (2013) 375– 389 383
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Tig. 6. Haemorrhagic lesions in the brain of a C57Bl/6J mouse infected
ith T. cati on day 7 p.i. (Institute for Parasitology, archive).
997). Similar neuropathological changes predominantly
n the heavily myelated tracts of the brain such as the
orpus callosum, internal and external capsules, cerebel-
ar  peduncles and cerebellar medulla have been described
y  Summers et al. (1983) and Dolinsky et al. (1985). These
ndings lead to the conclusion of larval afﬁnity to the
hite  matter of the brain (Holland and Hamilton, 2006).
ardillo et al. (2009) reported macroscopic lesions such as
potted  haemorrhagic foci on the cortex surface of mouse
rains  during the ﬁrst week of infection with T. canis
Fig. 6). Histologically, areas of haemorrhage, congestion
nd neuronal necrosis without reaction of the microglia
ould be detected. Furthermore, haemorrhagic foci in lungs
Fig.  7) and kidneys (Fig. 8) of infected animals as well as
arenchymatose congestion in the kidneys and areas of red
epatisation and haemorrhagic lung consolidation were
oted  by the authors. Larvae in the skeletal muscle and
ig. 7. Haemorrhagic lesions in the lung of a C57Bl/6J mouse infected with
.  canis on day 2 p.i. (Institute for Parasitology, archive).Fig. 8. Toxocara spp. larva near the renal cortex (Institute for Parasitology,
archive).
other organs of paratenic hosts are enclosed in granulomas
with exception of the CNS (Burren, 1968; Kayes and Oaks,
1978;  Parsons, 1987). Despite the lack of inﬂammatory cell
inﬁltrates,  increased blood-brain barrier permeability and
enhanced  expression of brain injury-associated biomarkers
such  as TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP as well
as  Tau occur in the course of Toxocara spp. brain infection
(Liao et al., 2008a,b).
Although the utility of the mouse model is proven for
the  investigation of a broad spectrum of aspects regarding
Toxocara spp. infections, mice show a rather low incidence
of  OLM after oral infection with T. canis in some studies
(Burren, 1968; Ghafoor et al., 1984). This and the time-
consuming investigation of mice eyeballs led Akao (2006)
to  question the suitability of the mouse model for the
investigation of OLM. Nevertheless, a study carried out by
Stangogiannis et al. (2007) reported “some degree of ocular
damage  in one or both eyes” of the experimentally infected
mice  although segments of larvae could only be recovered
from two  eyes with no directly associated inﬂammatory
reaction. In consistence with the ﬁndings in humans, larvae
were  mainly found at the posterior pole. However, granulo-
matous lesions have rarely been reported in mice or gerbils,
a  novel animal model for OLM (Akao, 2006; Ghafoor et al.,
1984).  These differences to the clinical picture in humans
may  be partly due to the relatively early stage of infec-
tion in laboratory animals as compared to humans, which
develop the condition after several years (Taylor, 2006).
Ocular lesions in mice most commonly comprise vitreal and
retinal  haemorrhages, uveitis, iridocyclitis, retinal vasculi-
tis,  microinfarcts, lymphocytic and haemorrhagic vitreal
inﬁltrates (Ghafoor et al., 1984; Taylor, 2006).
Mongolian gerbils (Meriones unguiculatus) are very sus-
ceptible to OLM by T. canis and T. cati (Takayanagi et al.,
1999;  Akao et al., 2000). Compared to mice, the incidence
of  OLM in gerbils after oral infection has been stated as high
as  90% (Alba-Hurtado et al., 2000). The types of ocular path-
omorphology recorded are similar to the ones observed in
mice,  including vitreous and retinal haemorrhages, exuda-
tive  lesions and vasculitis (Akao, 2006). Additionally, a
study  carried out by Alba-Hurtado et al. (2000) revealed
granulomatous lesions towards the end of the observa-
tion period (60 days p.i.) similar to the picture described
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in humans. Mongolian gerbils frequently develop neuro-
logical symptoms such as gait difﬁculty, progressive ataxia,
paraplegia, urinary incontinence and coma. Histopatholog-
ical changes are mostly limited to the cerebellum area and
present  as a loss of Purkinje cells, glial ﬁbres and nerve
sheaths. These changes also occurred independently of the
presence  of larvae and were generally less severe in T. cati-
than  in T. canis-infected gerbils (Akao et al., 2003b; Akao,
2006).
Only  a few investigations regarding Toxocara spp. infec-
tion  have been carried out using a rat model, although it
is  considered to be of similar scientiﬁc value as the mouse
model (Olson and Rose, 1966; Burren, 1968; Schaffer et al.,
1992;  Okada et al., 1996; Akao, 2006; Chiefﬁ et al., 2010).
However, for investigations on OLM the rat model cannot
be  recommended, since OLM in rats is even less common
than in mice (Burren, 1972).
The pig has been considered a useful animal model for
human covert toxocarosis and VLM since T. canis larvae
exhibit an extensive migration pattern and induce a strong
immune  response (Helwigh et al., 1999; Taira et al., 2004).
Taira  et al. (2003b, 2004) demonstrated a lack of clinical
symptoms in infected pigs despite extended larval migra-
tion  and the presence of pathological changes in different
tissues. The organs most severely affected by pathological
changes due to larval migration were liver, kidneys, lungs
and  lymph nodes (Helwigh et al., 1999; Sommerfelt et al.,
2004).  On the surface of liver and kidneys numerous white
spots,  similar to those commonly observed during Ascaris
suum  infection, were detected. Livers appeared white and
ﬁbrotic,  whereas lungs showed numerous granulomas and
consolidation (Helwigh et al., 1999; Sommerfelt et al.,
2004).  Another study additionally revealed severe patho-
logical  aberrations in the brain such as congestion, oedema,
shrinkage of nerve cells, vacuolization, gliosis, satellito-
sis,  neurophagia and liquefactive necrosis (Sasmal et al.,
2008).  The disease in the pig shows a clear capacity of
self-limitation since there is a signiﬁcant decrease in lar-
val  numbers over time and the lesions show a tendency to
heal  from 28 days p.i. on (Sommerfelt et al., 2004).
In chickens no clinical symptoms have been described
after experimental infection with T. cati or T. canis (Galvin,
1964; Taira et al., 2003a, 2011). Pathological ﬁndings
during T. cati infection in chickens mainly include haemor-
rhagic areas and foci of necrosis in the liver and to a lesser
extent in the lungs and kidneys 3–14 days p.i. (Azizi et al.,
2007).  Oryan et al. (2010) reported lymphocytic peribroni-
chiolitis with BALT hyperplasia and mild haemorrhages,
lymphocytic and eosinophilic inﬁltration of the meninges
covering the cerebellum as well as perivascular cufﬁng in
some  areas of the cerebellum as late as 240 days after T. cati
infection.
6.  Diagnosis and treatment of toxocarosis in the
paratenic host
6.1.  DiagnosisIn  humans, lesions caused by Toxocara spp. larvae can
be  detected with various medical imaging techniques, such
as  ultrasound, computed tomography (CT) and magneticlogy 193 (2013) 375– 389
resonance imaging (MRI) (Dupas et al., 1986; Ruttinger
and Hadidi, 1991; Baldisserotto et al., 1999). Addition-
ally, biopsy and subsequent histopathological examination
using a special staining technique leads to a deﬁnite diag-
nosis  (Parsons et al., 1986). However, the most commonly
used diagnostic methods are serological techniques such
as  the enzyme-linked immunosorbent assay (ELISA) with
Toxocara spp. excretory-secretory (TES) antigen or Western
blot  (de Savigny et al., 1979; Magnaval et al., 1991). Pos-
itive  ELISA test results have to be interpreted cautiously
since cross reactions due to other parasitic infections
may  occur. Furthermore, TES-antigen contains parasite-
derived human A and B blood group-like substances, which
could  interfere with anti-A or -B isohaemagglutinins in
human  sera (van Knapen et al., 1983; Smith et al., 1984;
Overgaauw, 1997a). To overcome these difﬁculties, an IgE-
ELISA  has been suggested for differential diagnosis since
the  above mentioned interfering antibodies are mainly of
the  IgG class (Girdwood, 1986; Magnaval et al., 1992).
In  experimentally infected animals, seroconversion was
detected between 4 days and 4 weeks p.i. and persisted
for months to years (Cypess et al., 1977; van Knapen
et al., 1982; Glickman and Summers, 1983; Overgaauw,
1997a). Seroconversion in mice was induced by merely
ﬁve  infective eggs (Kayes et al., 1985; Girdwood, 1986). For
interpretation of serological results in humans, it has been
proposed that a seropositivity alone is of little clinical sig-
niﬁcance, only the combination of seropositivity and blood
eosinophilia is indicative of active toxocarosis (Magnaval
et  al., 2001). Furthermore, patients may  suffer from OLM
whilst  serologically negative. This is probably due to a
lower  larval burden combined with a prolonged interval
between infection and testing (Overgaauw, 1997a). In gen-
eral,  only patients with clinical signs of a Toxocara spp.
infection are eligible for therapy (Magnaval et al., 2001).
6.2.  Treatment
Most anthelmintic drug efﬁciency studies have been
carried out on experimentally infected mice (Magnaval and
Glickman,  2006). A large number of substances has been
tested and revealed larvicidal or anti-migratory effects
(Dafalla, 1972; Abdel-Hameed, 1984; Abo-Shehada and
Herbert,  1984b; Bardón et al., 1995; Fok and Kassai, 1998;
Reis  et al., 2010). Fok and Kassai (1998) assessed the
larval reduction in mice experimentally infected with T.
canis  following treatment with albendazole, fenbendazole,
ﬂubendazole, oxibendazole or ivermectin. They recorded
high  larvicidal activities of these substances with reduc-
tions  of mean group larval counts of 81.1% or 88.2% for
a  20 day course of oxibendazole or ﬂubendazole and
98.8% or 100% for a 30 day course of fenbendazole or
albendazole. Similar larvicidal effects have been described
for  diethylcarbamazinen (DEC) administered intraperi-
toneally on three consecutive days (Dafalla, 1972). By
contrast, ivermectin and mebendazole exhibited only mod-
erate  larvicidal activities (Bardón et al., 1995; Fok and
Kassai, 1998). An inhibition of larval migration com-
bined with minor larvicidal potential has been reported
for thiabendazole (Abdel-Hameed, 1984). Similar anti-
migratory effects with enhancement of liver-entrapment
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f larvae have been observed with levamisole, ivermectin,
lbendazole and fenbendazole (Abo-Shehada and Herbert,
984b). An enhanced larvicidal activity has been reported
or  albendazole or fenbendazole, co-administered with
he  immunomodulator glucan, incorporated in stabilized
iposomes (Hrcˇkova,  2006; Hrcˇkova  et al., 2007). The
uthors postulate that the effectiveness of benzimida-
ole treatment is markedly improved by the liposomal
rug formulation, as it solves solubility problems and
cts  as a slow-releasing drug reservoir (Fielding, 1991).
nother recent study evaluated the larvicidal effects of dif-
erent  natural products in vivo and in vitro (Reis et al.,
010). A hexane extract of the herb Chenopodium ambro-
ioides as well as Nutridesintox®, a plant-based nutritional
upplement, revealed larvicidal activity in vitro, but the
ubstances were not particularly effective in reducing the
arval  burden in vivo (Reis et al., 2010).
Despite the wide range of substances tested in ani-
al  models, only few drugs are available for treatment in
umans  (Magnaval et al., 2001). Albendazole, mebendazole
nd thiabendazole have been assessed in controlled ran-
omized  studies in human patients and resulted in 47%,
0%,  or 50–53% reduction of clinical symptoms, respec-
ively (Magnaval and Charlet, 1987; Stürchler et al., 1989).
ide  effects such as dizziness, nausea and abdominal
ain were observed in 47–70% of patients (Magnaval and
harlet, 1987; Stürchler et al., 1989; Magnaval, 1995). Sub-
tances  should be administered with a fatty meal as one of
heir  major disadvantages is the low absorption rate from
he  gastrointestinal tract (Magnaval et al., 2001; Magnaval
nd  Glickman, 2006). Attempts to overcome this difﬁculty
ave  been made using liposome formulations as described
bove (Hrcˇkova,  2006; Hrcˇkova  et al., 2007). According to
espommier (2003), albendazole at 10 mg/kg bw per day
n  two divided doses is the treatment of choice.
Ivermectin did not exhibit greater larvicidal potential
n humans than it did in mice, and is not recommended
or the treatment of human toxocarosis (Magnaval et al.,
001).  For DEC, a 70% reduction of clinical signs along with
8%  of patients showing side effects has been reported.
ide effects comprised hypersensitivity reactions such as
tching,  urticaria and oedema which have been attributed
o  accelerated larval lysis (Magnaval, 1995). To reduce
nﬂammation and to control hypersensitivity reactions to
ying  larvae, corticosteroids are frequently used, espe-
ially  for treatment of OLM (Girdwood, 1986; Magnaval
t al., 2001; Despommier, 2003). For treatment of OLM,
enetration of the human eye by the anthelmintic agent
s  an important factor. In contrast to the benzimidazole
erivates, DEC shows this feature, which is known from
xperience, gained from the treatment of human onchocer-
iasis  (Dadzie et al., 1987; Magnaval et al., 2001). DEC is
nhibited by corticosteroids; therefore, those substances
hould not be administered in combination (Maizels and
enham,  1992). Other treatment options for OLM comprise
aser  photocoagulation (Gass and Braunstein, 1983; Casella
t  al., 1998), cryopexie (El Marti et al., 1990; Zygulska-Mach
t al., 1993) and pars plana vitrectomy (Werner et al., 1999).
ith  exception of OLM, the most suitable method for
ost-treatment follow-up of clinical toxocarosis in humans
ppears  to be eosinophil blood count, which decreaseslogy 193 (2013) 375– 389 385
signiﬁcantly within one month of treatment (Magnaval,
1995; Magnaval et al., 2001).
7. Conclusions
In all species of paratenic hosts examined so far, the
general principle of somatic migration of Toxocara spp. lar-
vae  is comparable, as it always comprises affection of the
liver  and the lungs. Commonly, larvae hatch after consump-
tion,  penetrate the intestinal wall and during the so called
hepato-pulmonary phase migrate via circulatory system to
the  liver, where they mostly persist. Some continue migra-
tion  to the heart and lungs into the systemic circulation.
During the visceral phase, they are distributed throughout
the entire body according to species-dependent predilec-
tion  sites. Migratory routes of both, T. canis and T. cati
appear to be similar with T. canis migrating to the CNS more
rapidly.  Additionally, host species- and strain dependent
differences regarding the neuroafﬁnity of migrating lar-
vae  have been described. The underlying reasons for the
strong  neuroafﬁnity and high susceptibility to OLM in some
paratenic host species, especially the gerbil, are still to
be  uncovered. Despite extensive studies on the migra-
tory behaviour and transmission routes of Toxocara spp.
larvae  in the past, some aspects such as the overall rel-
evance of prenatal and lactogenic transmission of both
T.  canis and T. cati larvae in the paratenic host remain
to be investigated. Furthermore, the high prevalence of
this  parasite in dogs and cats and subsequent difﬁculties
in preventing environmental contamination and human
infection highlight its unquestionable importance as a
zoonosis.  The nature of pathological alterations in tox-
ocarosis in humans and other paratenic hosts has been
described in detail and can be summarized as mainly haem-
orrhages, necrosis and granuloma formation in somatic
tissues as well as gliosis, demyelization and malacia in
the  CNS, predominantly the cerebellum. Furthermore, four
different  clinical forms of toxocarosis have been distin-
guished in humans, namely VLM, NT, OLM and covert
toxocarosis. Despite extensive studies, the broad spectrum
of  clinical and pathological consequences accompanying
toxocarosis is still poorly understood. Further research is
needed  to investigate the detailed mode of action of the
apparent immunopathological features of this helminth
infection, particularly as linkage of toxocarosis to various
immuno-related conditions in humans suggests a greater
pathogenic potential than expected and sheds a differ-
ent  light onto seemingly asymptomatic cases of human
toxocarosis.
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